BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6723774)

  • 1. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN
    Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
    Bhargava HN
    NIDA Res Monogr; 1984 Mar; 49():320-6. PubMed ID: 6148693
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an increase in [3H]spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the rat.
    Le Fur G; Guilloux F; Uzan A
    Clin Exp Hypertens A; 1983; 5(9):1537-42. PubMed ID: 6640968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The residual effect of chronic neuroleptic treatment on the neuroleptic binding assay in rats.
    Wan CW; Peck EJ; Ho BT; Schoolar JC
    Life Sci; 1983 Mar; 32(11):1255-62. PubMed ID: 6834989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
    Golombiowska-Nikitin K; Sontag KH; Osborne NN
    Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
    Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
    Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas.
    Lee JM; Ritzmann RF; Fields JZ
    Peptides; 1984; 5(1):7-10. PubMed ID: 6231532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (3H) spiroperidol binding decreases in brains of rats infected with Venezuelan equine encephalomyelitis virus.
    Bonilla E; Salazar M; Estevez J; Hernández H; Rangel P
    Experientia; 1984 Aug; 40(8):868-9. PubMed ID: 6468605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of REM sleep deprivation on striatal dopamine receptor sites.
    Zwicker AP; Calil HM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):809-12. PubMed ID: 3012593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.